Article

<em>Respiratory Syncytial Virus</em> Vaccine mRNA Lipid Nanoparticles Pattern Determined via Bioinformatics

2024-04-02

Abstract excerpt

<h4>Background: </h4> RSV, or respiratory syncytial virus, is a deadly condition that is present all over the world today. The infection is initially contained in the lower respiratory tract without systemic transmission. The objective of the study: Bioinformatics was used in Egypt to create an mRNA vaccine against the Respiratory syncytial virus (RSV). Methodology: In the present screening experimental study, a l...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7c137275-daa8-5d77-8630-c9fa49d3b6fa
DOI: 10.20944/preprints202404.0162.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

<em>Respiratory Syncytial Virus</em> Vaccine mRNA Lipid Nanoparticles Pattern Determined via BioinformaticsDOI 10.20944/preprints202404.0162.v1Read

Respiratory syncytial virus vaccine mRNA lipid nanoparticles pattern determined via bioinformaticsSemantic proximity Read

Design of Lipid Nanoparticles of mRNA Vaccine against Respiratory Syncytial Virus by Bioinformatics in EgyptSemantic proximity Read

Robust and Long-Lasting Immunity and Protection in Mice Induced by Lipopolyplex-Delivered mRNA Vaccines Expressing the Prefusion Protein of Respiratory Syncytial VirusSemantic proximity Read

Rational design of respiratory syncytial virus dimeric F-subunit vaccines in protein and mRNA formsSemantic proximity Read

Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progressSemantic proximity Read

Efficacy and safety of an mRNA-based RSV preF vaccine in preclinical studiesSemantic proximity Read

Improved mRNA-based RSV vaccine with PreF forming enveloped virus-like particlesSemantic proximity Read

Harnessing Computational Strategies to Overcome Challenges in mRNA VaccinesSemantic proximity Read

A new vaccine strategy based on VLSs for use against SARS-CoV-2 variants: Evaluation of their immune effectiveness and investigation of the mechanismSemantic proximity Read

Elasomeran (mRNA1273) Vaccine: The Journey from Preclinical Research to Clinical Trials, Authorization, and FDA ApprovalSemantic proximity Read

An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine DevelopmentSemantic proximity Read

The Unique Features and Collateral Immune Effects of mRNA-Based COVID-19 Vaccines: Potential Plausible Causes of Adverse Events and ComplicationsSemantic proximity Read